β3-integrin cytoplasmic binding proteins

Archivum Immunologiae et Therapiae Experimentalis

Volumn 52, Issue 5, 2004, Pages 348-355

  Zhao, Renyi ^a   Pathak, Alokkumar S ^a   Stouffer, George A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cytoplasmic domains; Integrins; Intracellular factors

Indexed keywords

BETA3 INTEGRIN; BINDING PROTEIN; INTEGRIN; INTEGRIN RECEPTOR; MEMBRANE PROTEIN; TYROSINE KINASE RECEPTOR; VITRONECTIN RECEPTOR;

APOPTOSIS; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURFACE; ENZYME ACTIVITY; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALPAIN; CARRIER PROTEINS; CYTOPLASM; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTEGRIN BETA3; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN-TYROSINE KINASES; PROTEINS; SIGNAL TRANSDUCTION; TALIN;

EID: 10344228268     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Aplin A. E., Howe A., Alahari S. K. and Juliano R. L. (1998): Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev., 50, 197-263.
2. Auerbach D., Bantle S., Keller S., Hinderling V., Leu M., Ehler E. and Perriard J. C. (1999): Different domains of the M-band protein myomesin are involved in myosin binding and M-band targeting. Mol. Biol. Cell, 10, 1297-1308.
3. Bar-Shavit R., Sabbah V., Lampugnani M. G., Marchisio P. C., Fenton J. W., Vlodavsky I. and Dejana E. (1991): An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion. J. Cell Biol., 112, 335-344.
4. 3 integrin associates with a 190-kDa protein that is phosphorylated on tyrosine in response to platelet-derived growth factor. J. Biol. Chem., 268, 17270-17276.
5. 3 on platelets and lymphocytes binds to the matrix protein ostcopontin. J. Biol. Chem., 272, 8137-8140.
6. Besta F., Massberg S., Brand K., Muller E., Page S., Gruner S., Lorenz M., Sadoul K., Kolanus W., Lengyel E. and Gawaz M. (2002): Role of β(3)-endonexin in the regulation of NF-κB-dependent expression of urokinase-type plasminogen activator receptor. J. Cell Sci., 115, 3879-3888.
7. 1 integrin function: confirmed, new and revised roles for a crucial family of cell adhesion molecules. J. Cell Sci., 110, 2895-2904.
8. 3 binds prothrombin and influences its activation. J. Biol. Chem., 272, 27183-27188.
9. 3 on vascular cells controls recognition of prothrombin. J. Cell Biol., 143, 2081-2092.
10. 3 in vascular biology. Thromb. Haemost., 80, 726-734.
11. Calderwood D. A., Fujioka Y., de Pereda J. M., Garcia-Alvarez B., Nakamoto T., Margolis B., McGlade C. J., Liddington R. C. and Ginsberg M. H. (2003): Integrin β cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc. Natl. Acad. Sci. USA, 100, 2272-2277.
12. Calderwood D. A., Huttenlocher A., Kiosses W. B., Rose D. M., Woodside D. G., Schwartz M. A. and Ginsberg M. H. (2001): Increased filamin binding to β-integrin cytoplasmic domains inhibits cell migration. Nat. Cell Biol., 3, 1060-1068.
13. Calderwood D. A., Shattil S. J. and Ginsberg M. H. (2000): Integrins and actin filaments: Reciprocal regulation of cell adhesion and signaling. J. Biol. Chem., 275, 22607-22610.
14. Calderwood D. A., Yan B., de Pereda J. M., Alvarez B. G., Fujioka Y., Liddington R. C. and Ginsberg M. H. (2002): The phosphotyrosine binding-like domain of talin activates integrins. J. Biol. Chem., 277, 21749-21758.
15. Carafoli E. and Molinari M. (1998): Calpain: a protease in search of a function? Biochem. Biophys. Res. Commun., 247, 193-203.
16. Cooray P., Yuan Y., Schoenwaelder S. M., Mitchell C. A., Salem H. H. and Jackson S. P. (1996): Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain. Biochem. J., 318, 41-47.
17. Croall D. E. and DeMartino G. N. (1991): Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev., 71, 813-847.
18. Davis S., Lu M. L., Lo S. H., Lin S., Butler J. A., Druker B. J., Roberts T. M., An Q. and Chen L. B. (1991): Presence of an SH2 domain in the actin-binding protein tensin. Science, 252, 712-715.
19. Dedhar S., Williams B. and Hannigan G. (1999): Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. Trends Cell Biol., 9, 319-323.
20. 3 subunit. J. Biol. Chem., 270, 26146-26151.
21. 3-endonexin. J. Biol. Chem., 272, 7693-7698.
22. v integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest., 103, 1227-1230.
23. Frid M. G., Printseva O. Y., Chiavegato A., Faggin E., Koteliansky V. E., Pauletto P., Glukhova M. A. and Sartore S. (1993): Myosin heavy-chain composition in developing and adult human aortic smooth muscle. J. Vasc. Res., 30, 279-292.
24. Garcia-Alvarez B., de Pereda J. M., Calderwood D. A., Ulmer T. S., Critchley D., Campbell I. D., Ginsberg M. H. and Liddington R. C. (2003): Structural determinants of integrin recognition by talin. Mol. Cell, 11, 49-58.
25. Gawaz M., Besta F., Ylanne J., Knorr T., Dierks H., Bohm T. and Kolanus W. (2001): The NITY motif of the β-chain cytoplasmic domain is involved in stimulated internalization of the β3 integrin A isoform. J. Cell Sci., 114, 1101-1113.
26. Goldmann W. H. (2000): Kinetic determination of focal adhesion protein formation. Biochem. Biophys. Res. Commun., 271, 553-557.
27. Golomb E., Ma X., Jana S. S., Preston Y. A., Kawamoto S., Shoham N. G., Goldin E., Conti M. A., Sellers J. R. and Adelstein R. S. (2004): Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. J. Biol. Chem., 279, 2800-2808.
28. Grainger D. J., Hesketh T. R., Metcalfe J. C. and Weissberg P. L. (1991): A large accumulation of non-muscle myosin occurs at first entry into M phase in rat vascular smooth-muscle cells. Biochem. J., 277, 145-151.
29. Hanks S. K. and Polte T. R. (1996): Signaling through focal adhesion kinase. Bioessays, 19, 137-145.
30. Hannigan G. E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M. G., Radeva G., Filmus J., Bell J. C. and Dedhar S. (1996): Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase. Nature, 379, 91-96.
31. Hapke S., Gawaz M., Dehne K., Kohler J., Marshall J. F., Graeff H., Schmitt M., Reuning U. and Lengyel E. (2001): β(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter. Mol. Cell Biol., 21, 2118-2132.
32. Horwitz A., Duggan K., Buck C., Beckerle M. C. and Burridge K. (1986): Interaction of plasma membrane fibronectin receptor with talin - a transmembrane linkage. Nature, 320, 531-533.
33. Hynes R. O. (1992): Integrins: versatility, modulation and signalling in cell adhesion. Cell, 69, 11-25.
34. Hynes R. O. (2002): Integrins: bidirectional, allosteric signaling machines. Cell, 110, 673-687.
35. Jenkins A. L., Nannizzi-Alaimo L., Silver D., Sellers J. R., Ginsberg M. H., Law D. A. and Phillips D. R. (1998): Tyrosine phosphorylation of the β3 cytoplasmic domain mediates integrin-cytoskeletal interactions, J. Biol. Chem., 273, 13878-13885.
36. 3 integrin cytoplasmic tail. J. Cell Biol., 137, 1433-1443.
37. Kawamoto S. and Adelstein R. S. (1987): Characterization of myosin heavy chains in cultured aorta smooth muscle cells. J. Biol. Chem., 262, 7282-7288.
38. Li D., Desai-Yajnik V., Lo E., Schapira M., Abagyan R. and Samuels H. H. (1999): NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors. Mol. Cell Biol., 19, 7191-7202.
39. Li F., Zhang Y. and Wu C. (1999): Integrin-linked kinase is localized to cell-matrix focal adhesions but not cell-cell adhesion sites and the focal adhesion localization of integrin-linked kinase is regulated by the PINCH-binding ANK repeats. J. Cell Sci., 112, 4589-4599.
40. Liu S., Calderwood D. A. and Ginsberg M. H. (2000): Integrin cytoplasmic domain-binding proteins. J. Cell Sci., 113, 3563-3571.
41. Lo S. H., An Q., Bao S., Wong W. K., Liu Y., Janmey P. A., Hartwig J. H. and Chen L. B. (1994): Molecular cloning of chick cardiac muscle tensin. Full-length cDNA sequence, expression, and characterization. J. Biol. Chem., 269, 22310-22319.
42. Martel V., Racaud-Sultan C., Dupe S., Marie C., Paulhe F., Galmiche A., Block M. R. and Albiges-Rizo C. (2001): Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides. J. Biol. Chem., 276, 21217-21227.
43. 1 from an early compartment of the secretory pathway. J. Cell Sci., 113, 1951-1961.
44. Murakami N., Kotula L. and Hwang Y. W. (2000): Two distinct mechanisms for regulation of nonmuscle myosin assembly via the heavy chain: phosphorylation for MIIB and mts 1 binding for MIIA. Biochemistry, 39, 11441-11451.
45. Obungu V. H., Lee B. A., Agarwal S. K., Chandrasekharapa S. C., Adelstein R. S. and Marx S. J. (2003): Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain. Oncogene, 22, 6347-6358.
46. Oda A., Druker B. J., Ariyoshi H., Smith M. and Salzman E. W. (1993): pp60src is an endogenous substrate for calpain in human blood platelets. J. Biol. Chem., 268, 12603-12608.
47. Ohta Y., Suzuki N., Nakamura S., Hartwig J. H. and Stossel T. P. (1999): The small GTPase RalA targets filamin to induce filopodia. Proc. Natl. Acad. Sci. USA, 96, 2122-2128.
48. 3-Endonexin as a novel inhibitor of cyclin A-associated kinase. Biochem. Biophys. Res. Commun., 267, 947-952.
49. 3-endonexin mutants for their ability to interact with cyclin A. Mol. Genet. Genomics, 266, 664-671.
50. O'Toole T. E., Katagiri Y., Faull R. J., Peter K., Tamura R., Quaranta V., Loftus J. C., Shattil S. J. and Ginsberg M. H. (1994): Integrin cytoplasmic domains mediate inside-out signal transduction. J. Cell Biol., 124, 1047-1059.
51. O'Toole T. E., Ylanne J. and Culley B. M. (1995): Regulation of integrin affinity states through an NPXY motif in the β subunit cytoplasmic domain. J. Biol. Chem., 270, 8553-8558.
52. 3 detected with a novel patch-engineered monovalent ligand. J. Biol. Chem., 274, 21609-21616.
53. Parsons J. T., Schaller M, D., Hildebrand J., Leu T., Richardson A. and Otey C. (1994): Focal adhesion kinase: structure and signalling. J. Cell Sci. Suppl., 18, 109-113.
54. 3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathwav. Thromb. Haemost., 88, 115-122.
55. Pawson T. and Scott J. D. (1997): Signaling through scaffold, anchoring, and adaptor proteins. Science, 278, 2075-2080.
56. Persad S. and Dedhar S. (2003): The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev., 22, 375-384.
57. Pfaff M., Du X. and Ginsberg M. H. (1999): Calpain cleavage of integrin β cytoplasmic domains. FEBS Lett., 460, 17-22.
58. Pfaff M., Liu S., Erle D. J. and Ginsberg M. H. (1998): Integrin β cytoplasmic domains differentially bind to cytoskeletal proteins. J. Biol. Chem., 273, 6104-6109.
59. Price M. G. (1987): Skelemins: cytoskeletal proteins located at the periphery of M-discs in mammalian striated muscle. J. Cell Biol., 104, 1325-1336.
60. Price M. G. and Gomer R. H. (1993): Skelemin, a cytoskeletal M-disc periphery protein, contains motifs of adhesion/recognition and intermediate filament proteins. J. Biol. Chem., 268, 21800-21810.
61. Priddle H., Hemmings L., Monkley S., Woods A., Patel B., Sutton D., Dunn G. A., Zicha D. and Critchley D. R. (1998): Disruption of the talin gene compromises focal adhesion assembly in undifferentiated but not differentiated embryonic stem cells. J. Cell Biol., 142, 1121-1133.
62. Radeva G., Petrocelli T., Behrend E., Leung-Hagesteijn C., Filmus J., Slingerland J. and Dedhar S. (1997): Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J. Biol. Chem., 272, 13937-13944.
63. Reddy K. B., Bialkowska K. and Fox J. E. (2001): Dynamic modulation of cytoskeletal proteins linking integrins to signaling complexes in spreading cells. Role of skelemin in initial integrin-induced spreading. J. Biol. Chem., 276, 28300-28308.
64. 3-integrins in non-muscle cells. J. Biol. Chem., 273, 35039-35047.
65. 1 cytoplasmic domain implicated in cytoskeletal association. J. Cell Biol., 117, 1321-1330.
66. Reusch P., Wagdy H., Reusch R., Wilson E. and Ives H. E. (1996): Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. Circ. Res., 79, 1046-1053.
67. Rovner A. S., Murphy R. A. and Owens G. K. (1986): Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J. Biol. Chem., 261, 14740-14745.
68. Saido T. C., Sorimachi H. and Suzuki K. (1994): Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J., 8, 814-822.
69. 3 integrins, nonmuscle myosin heavy chain-A and focal adhesion kinase form in thrombospondin-treated smooth muscle cells. J. Investig. Med., 48, 190-197.
70. Sartore S., Chiavegato A., Franch R., Faggin E. and Pauletto P. (1997): Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models, and in vascular disease. Arterioscler Thromb. Vasc. Biol., 17, 1210-1215.
71. Sartore S., Scatena M., Chiavegato A., Faggin E., Giuriato L. and Pauletto P. (1994): Myosin isoform expression in smooth muscle cells during physiological and pathological vascular remodeling. J. Vasc. Res., 31, 61-81.
72. Schaller M. D., Otey C. A., Hildebrand J. D. and Parsons J. T. (1995): Focal adhesion kinase and paxillin bind to peptides mimicking β integrin cytoplasmic domains, J. Cell Biol., 130, 1181-1187.
73. Schlaepfer D. D., Hanks S. K., Hunter T. and van der Geer P. (1994): Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature, 372, 786-791.
74. Schlaepfer D. D. and Hunter T. (1996): Signal transduction from the extracellular matrix - a role for the focal adhesion protein-tyrosine kinase FAK. Cell Struct. Funct., 21, 445-450.
75. Schlaepfer D. D. and Hunter T. (1998): Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol., 8, 151-157.
76. 3 Integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF. EMBO J., 16, 5600-5607.
77. Sellers J. R. (2000): Myosins: a diverse superfamily. Biochim. Biophys. Acta, 1496, 3-22.
78. 3 subunit. J. Cell Biol., 131, 807-816.
79. Solowska J., Guan J. L., Marcantonio E. E., Trevithick J. E., Buck C. A. and Hynes R. O. (1989): Expression of normal and mutant avian integrin subunits in rodent cells. J. Cell Biol., 109, 853-861.
80. 3 integrins. J. Biol. Chem., 271, 10365-10371.
81. Suzuki K. and Sorimachi H. (1998): A novel aspect of calpain activation. FEBS Lett., 433, 1-4.
82. Tadokoro S., Shattil S. J., Eto K., Tai V., Liddington R. C., de Pereda J. M., Ginsberg M. H. and Calderwood D. A. (2003): Talin binding to integrin β tails: a final common step in integrin activation. Science, 302, 103-106.
83. 3 cytoplasmic domain in triggering focal adhesion kinase phosphorylation. J. Biol. Chem., 272, 7892-7898.
84. -/- human colon carcinoma cells. Oncogene, 20, 133-140.
85. Tan C., Cruet-Hennequart S., Troussard A., Fazli L., Costello P., Sutton K., Wheeler J., Gleave M., Sanghera J. and Dedhar S. (2004): Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell, 5, 79-90.
86. 3-integrin. Am. J. Physiol. Cell Physiol., 283, C1501-C1510.
87. Vuori K. and Ruoslahti E. (1994): Association of insulin receptor substrate-1 with integrins. Science, 266, 1576-1578.
88. Wei Q. and Adelstein R. S. (2000): Conditional expression of a truncated fragment of nonmuscle myosin II-A alters cell shape but not cytokinesis in HeLa cells. Mol. Biol. Cell, 11, 3617-3627.
89. Whittaker C. A. and Hynes R. O. (2002): Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol. Biol. Cell, 13, 3369-3387.
90. Wu C. and Dedhar S. (2001): Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J. Cell Biol., 155, 505-510.
91. Yamaguchi R., Maki M., Hatanaka M. and Sabe H. (1994): Unphosphorylated and tyrosine-phosphorylated forms of a focal adhesion protein, paxillin, are substrates for calpain II in vitro: implications for the possible involvement of calpain II in mitosis-specific degradation of paxillin. FEBS Lett., 356, 114-116.
92. 3 integrin cytoplasmic domain. J. Biol. Chem., 276, 28164-28170.
93. vβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA, 95, 11217-11222.